Tallas Biotech Inc.
Tallas Biotech is dedicated to building cutting-edge AI algorithms combined with laboratory research to develop RNAi drugs for previously 'undruggable' conditions. Their mission is to enable the next wave of therapies by leveraging rapid growth in computing power to transform drug research, making it faster, cheaper, and with less failure.
Industries
artificial-intelligence
biopharma
biotechnology
health-care
pharmaceutical
Nr. of Employees
small (1-50)
Tallas Biotech Inc.
Products
RNAi therapeutic development programs (discovery-stage)
Indication-focused RNAi therapeutic programs in early discovery intended to progress toward preclinical development.
Programs targeting specific indications
Discovery-stage programs referenced for hereditary hemochromatosis and pancreatic cancer.
RNAi therapeutic development programs (discovery-stage)
Indication-focused RNAi therapeutic programs in early discovery intended to progress toward preclinical development.
Programs targeting specific indications
Discovery-stage programs referenced for hereditary hemochromatosis and pancreatic cancer.
Services
AI-enabled RNAi discovery service
Collaborative or internal discovery service combining computational design and laboratory validation to generate and optimize RNAi therapeutic candidates.
AI-enabled RNAi discovery service
Collaborative or internal discovery service combining computational design and laboratory validation to generate and optimize RNAi therapeutic candidates.
Expertise Areas
- RNAi drug discovery
- AI-driven molecular design
- Computational–experimental integration
- Target identification and validation
Key Technologies
- RNA interference (RNAi)
- Machine learning for molecular design
- Computational drug discovery platforms
- In silico target identification